课题基金 / 基金详情

SCH: INT: Collaborative Research: S.E.P.S.I.S.: Sepsis Early Prediction Support Implementation System

SCH: INT: Collaborative Research: S.E.P.S.I.S.: Sepsis Early Prediction Support Implementation System
SCH:INT:合作研究:S.E.P.S.I.S.:败血症早期预测支持实施系统
批准号:
1522072
负责人:
Muge Capan
金额:
$35.14万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-10-01 至 2018-06-30

项目摘要

项目成果

Muge Capan的其他基金

相似基金

相关文献

中文摘要
翻译
脓毒症,感染加上全身感染的表现,是院内死亡的主要原因。美国医院每年约有70万人死亡,其中16%被诊断为败血症(包括高患病率的严重败血症和主要并发症)。除了致命之外,败血症是与住院有关的最昂贵的疾病,导致住院时间比任何其他疾病长75%。脓毒症对美国医疗保健系统的总负担估计为203亿美元,其中大部分由医疗保险和医疗补助支付。事实上,2015年6月,医疗保险和医疗补助服务中心(CMS)报告称,败血症占医疗保险支付的70多亿美元(仅次于主要关节置换术),比前一年增加了近10%。这种对卫生保健资源的普遍消耗,部分原因是诊断困难和治疗延误。例如,严重败血症/休克的抗生素治疗每延迟一小时,患者的生存几率就会降低10%。如果有更好的医疗系统,其中许多死亡是可以避免或推迟的。本研究的目标是通过整合电子健康记录(EHR)和临床专业知识来克服这些障碍,提供一个基于证据的框架来诊断和准确地对脓毒症谱内的患者进行风险分层,并制定和验证干预政策,为脓毒症治疗决策提供信息。该项目旨在将医疗保健提供者、研究人员、教育工作者和学生聚集在一起,通过集成机器学习、决策分析模型、人为因素分析以及系统和流程建模来提高科学知识、预测败血症并预防败血症相关的健康恶化,从而为患者护理增加价值。除了这些发现的临床转化可能带来的社会影响外,该项目还将为工程和计算机科学专业的学生以及卫生服务研究人员提供跨学科的教育经验。拟议的研究将应用工程和计算机科学方法来分析两家大型医疗机构,梅奥诊所罗切斯特和克里斯蒂安娜保健卫生系统的患者水平电子病历,并为败血症的临床决策提供信息。多机构、跨学科的合作将通过描述和准确地对住院患者进行风险分层,以及开发决策分析模型来个性化和告知考虑患者结果和反应影响的诊断和治疗决策,从而实现败血症医疗保健解决方案的开发。脓毒症早期预测支持实施系统(S.E.P.S.I.S.)项目的目标是:1)开发数据驱动模型,根据患者的临床进展对患者进行分类,以诊断脓毒症并预测恶化风险,从而为治疗行动提供信息。2)针对脓毒症谱系患者制定个性化干预政策。3)开发决策支持系统(DSS),用于个性化干预措施,重点关注实际医院环境中的资源影响和可用性。该团队将1)根据贝叶斯指数族主成分分析确定揭示患者概况的重要因素;2)建立隐马尔可夫模型(hmm)和输入-输出hmm,以识别脓毒症谱系中具有相似进展模式的患者群;3)提供一个分析框架,支持脓毒症分期在临床实践中使用双层优化。他们将1)使用多元统计模型和模拟预测个体患者的短期和长期结果;2)建立半马尔可夫决策过程和部分可观察半马尔可夫决策过程模型,以确定治疗行动和诊断测试的时机。此外,该团队将1)预测资源需求,并开发和验证混合整数规划和排队模型,以优化系统级分配;2)利用人为因素分析和可用性测试来评估决策支持系统的实施情况。
英文摘要
Sepsis, infection plus systemic manifestations of infection, is the leading cause of in-hospital mortality. About 700,000 people die annually in US hospitals and 16% of them were diagnosed with sepsis (including a high prevalence of severe sepsis with major complication). In addition to being deadly, sepsis is the most expensive condition associated with in-hospital stay, resulting in a 75% longer stay than any other condition. The total burden of sepsis to the US healthcare system is estimated to be $20.3 billion, most of which is paid by Medicare and Medicaid. In fact, in June 2015 the Centers for Medicare & Medicaid Services (CMS) reported that sepsis accounted for over $7 billion in Medicare payments (second only to major joint replacement), a close to 10% increase from the previous year. This pervasive drain on health care resources is due, in part, to difficulties in diagnosis and delayed treatment. For example, every one hour delay in treatment of severe sepsis/shock with antibiotics decreases a patient's survival probability by 10%. Many of these deaths could have been averted or postponed if a better system of care was in place. The goal of this research is to overcome these barriers by integrating electronic health records (EHR) and clinical expertise to provide an evidence-based framework to diagnose and accurately risk-stratify patients within the sepsis spectrum, and develop and validate intervention policies that inform sepsis treatment decisions. The project to bring together health care providers, researchers, educators, and students to add value to patient care by integrating machine learning, decision analytical models, human factors analysis, as well as system and process modeling to advance scientific knowledge, predict sepsis, and prevent sepsis-related health deterioration. In addition to the societal impact that clinical translation of these findings may bring, the project will provide engineering and computer science students and health services researchers with cross-disciplinary educational experience.The proposed research will apply engineering and computer science methodologies to analyze patient level EHR across two large scale health care facilities, Mayo Clinic Rochester and Christiana Care Health System and to inform clinical decision making for sepsis. The multi-institutional, interdisciplinary collaboration will enable the development of health care solutions for sepsis by describing and accurately risk-stratifying hospitalized patients, and developing decision analytical models to personalize and inform diagnostic and treatment decisions considering patient outcomes and response implications. The Sepsis Early Prediction Support Implementation System (S.E.P.S.I.S.) project aims will be to: 1) Develop data-driven models to classify patients according to their clinical progression to diagnose sepsis and predict risk of deterioration, thus informing therapeutic actions. 2) Develop personalized intervention policies for patients within the sepsis spectrum. 3) Develop decision support systems (DSS) for personalized interventions focusing on resource implications and usability within a real hospital setting. The team will 1) identify important factors that uncover patient profiles based on Bayesian exponential family principal components analysis; 2) develop hidden Markov models (HMMs) and input-output HMMs to identify clusters of patients with similar progression patterns within the sepsis spectrum; 3) provide an analytical framework to support sepsis staging in clinical practice using bilevel optimization. They will 1) predict short- and long-term individual patient outcomes using multivariate statistical models and simulation; 2) develop semi-Markov decision process and partially observable semi-Markov decision process models to identify timing of therapeutic actions and diagnostic tests. Furthermore, the team will 1) predict demand for resources and develop and validate a hybrid mixed integer programming and queueing model to optimize system level allocations; 2) utilize human factors analysis and usability testing to assess the implementation of the DSS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCH: INT: Collaborative Research: S.E.P.S.I.S.: Sepsis Early Prediction Support Implementation System
  • 批准号:
    1833538
  • 项目类别:
    Standard Grant
  • 资助金额:
    $10.75万
  • 财政年份:
    2018
  • 负责人:
    Muge Capan
  • 依托单位:
国内基金
海外基金
内源性逆转录病毒MER65-int调控人类胎 盘发育与子宫内膜重塑的功能研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    屈雨亮
  • 依托单位:
隐秘重组信号序列INT-RSS在T细胞受体基因Tcra重排中的功能和机制研究
  • 批准号:
    32370939
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    郝冰涛
  • 依托单位:
HPV16 E7 通过 Int1 蛋白调控 Wnt 信号通路调节肿瘤局部树突状细胞活性
  • 批准号:
    LQ22H160033
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    陈婷婷
  • 依托单位:
选择性PPARγ激动剂INT131调控适应性产热和AD-MSCs分化成棕色样脂肪细胞的机制研究